Trade Summary

5 days ago, Heidbreder Christian, serving as Chief Scientific Officer at Indivior Pharmaceuticals, Inc. (INDV), sold 18,586 shares at $41.14 per share, for a total transaction value of $764,628.04. Following this transaction, Heidbreder Christian now holds 209,337 shares of INDV.

This sale represents a 8.15% decrease in Heidbreder Christian's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 10, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 4:31 PM ET, 3 days after the trade was made.

Indivior Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.